Clinical Pharmacokinetics

The Role of Population Pharmacokinetics in Drug Development in Light of the Food and Drug Administration's ‘Guidance for Industry: Population Pharmacokinetics’
pp. 385-395(11)
Authors: Williams P.J.; Ette E.I.

Clinical Pharmacokinetics of Pravastatin: Mechanisms of Pharmacokinetic Events
pp. 397-412(16)
Author: Hatanaka T.

Clinical Pharmacokinetics of Reboxetine, a Selective Norepinephrine Reuptake Inhibitor for the Treatment of Patients with Depression
pp. 413-427(15)
Author: Fleishaker J.C.

Clinical and Preclinical Pharmacokinetics of Raltitrexed
pp. 429-443(15)
Authors: Clarke S.J.; Beale P.J.; Rivory L.P.

Monitoring Antiplatelet Therapy: What is the Best Method?
pp. 445-458(14)
Authors: Mukherjee D.; Moliterno D.J.

Chiral Bioequivalence: Effect of Absorption Rate on Racemic Etodolac
pp. 459-469(11)
Authors: Boni J.P.; Korthbradley J.M.; Richards L.S.; Chiang S.T.; Hicks D.R.; Benet L.Z.